Dash Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30M

  • Investors
  • 11

Dash Bio General Information

Description

Developer of a clinical bioanalysis platform intended to offer tech-enabled services for drug development. The company's platform adapts a technology-first approach to developing critical services across the drug development lifecycle, aiming to build new capabilities that leverage AI, robotics, and fully integrated software to deliver GLP-compliant services, enabling users to automate critical steps, reduce costs, and shorten time to market without compromising on quality.

Contact Information

Website
www.dash.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 56 Broad Street
  • Suite 14011
  • Boston, MA 02109
  • United States
+1 (617)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 56 Broad Street
  • Suite 14011
  • Boston, MA 02109
  • United States
+1 (617)

Dash Bio Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dash Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 03-Aug-2026 $30M Completed Generating Revenue
2. Early Stage VC 26-Jun-2025 Completed Generating Revenue
1. Seed Round 08-Oct-2024 $6.47M $6.47M Completed Generating Revenue
To view Dash Bio’s complete valuation and funding history, request access »

Dash Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-3
Seed-2 3,035,390 $0.000010 $3.21 $3.21 1x $3.21 12.95%
Seed-1 3,632,576 $0.000010 $1.78 $1.78 1x $1.78 15.49%
To view Dash Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Dash Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dash Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oak HC/FT Venture Capital Minority
Cybernetix Ventures Venture Capital Minority
Drive Capital Venture Capital Minority
RTP Global Venture Capital Minority
The Aligned Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Dash Bio FAQs

  • When was Dash Bio founded?

    Dash Bio was founded in 2024.

  • Where is Dash Bio headquartered?

    Dash Bio is headquartered in Boston, MA.

  • What is the size of Dash Bio?

    Dash Bio has 41 total employees.

  • What industry is Dash Bio in?

    Dash Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Dash Bio a private or public company?

    Dash Bio is a Private company.

  • What is the current valuation of Dash Bio?

    The current valuation of Dash Bio is .

  • What is Dash Bio’s current revenue?

    The current revenue for Dash Bio is .

  • How much funding has Dash Bio raised over time?

    Dash Bio has raised $47.5M.

  • Who are Dash Bio’s investors?

    Oak HC/FT, Cybernetix Ventures, Drive Capital, RTP Global, and The Aligned Fund are 5 of 11 investors who have invested in Dash Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process